Xie XF, Zhang QY, Huang JY, Chen LP, et al. Pyrotinib combined with trastuzumab and chemotherapy for the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer: a single-arm exploratory phase II trial. Breast Cancer Res Treat 2022 Oct 30. pii: 10.1007/s10549-022-06770.
PMID: 36309908